Search research articles
Contact Us
Filters
Showing results (1-10 of 102) with videos related to
Page
of 11
Sort By:
Journal of Hospital Medicine
|
July 15, 2024
Clinical guideline highlights for the hospitalist: International consensus criteria for pediatric sepsis and septic shock
James A Watson, Nichole Samuy
Trials
|
May 9, 2020
Graphing and reporting heterogeneous treatment effects through reference classes
James A Watson, Chris C Holmes
Trials
|
February 12, 2020
Machine learning analysis plans for randomised controlled trials: detecting treatment effect heterogeneity with strict control of type I error
James A Watson, Chris C Holmes
The Journal of Infectious Diseases
|
August 16, 2021
Questioning the Claimed Superiority of Malaria Parasite Ex Vivo Viability Reduction Over Observed Parasite Clearance Rate?
Nicholas J White, James A Watson
The Lancet. Infectious Diseases
|
October 3, 2025
Reconsidering the clinical assessment of resistance to slowly eliminated antimalarial drugs in high-transmission settings
Nicholas J White, James A Watson
The New England Journal of Medicine
|
May 9, 2019
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
James A Watson, Aimee R Taylor
The New England Journal of Medicine
|
July 20, 2022
Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
James A Watson, Nicholas J White
Trials
|
October 21, 2020
Correction to: Graphing and reporting heterogeneous treatment effects through reference classes
James A Watson, Chris C Holmes
The Lancet. Microbe
|
May 11, 2022
Tafenoquine for the prevention of Plasmodium vivax malaria relapse
James A Watson, Narimane Nekkab, Michael White
Bioinformatics (Oxford, England)
|
August 11, 2020
A semi-supervised learning framework for quantitative structure-activity regression modelling
Oliver Watson, Isidro Cortes-Ciriano, James A Watson
Page
of 11
Search research articles
Search
Showing results (1-10 of 102) with videos related to
Sort By:
Page
of 11
Journal of Hospital Medicine
|
July 15, 2024
Clinical guideline highlights for the hospitalist: International consensus criteria for pediatric sepsis and septic shock
James A Watson, Nichole Samuy
Trials
|
May 9, 2020
Graphing and reporting heterogeneous treatment effects through reference classes
James A Watson, Chris C Holmes
Trials
|
February 12, 2020
Machine learning analysis plans for randomised controlled trials: detecting treatment effect heterogeneity with strict control of type I error
James A Watson, Chris C Holmes
The Journal of Infectious Diseases
|
August 16, 2021
Questioning the Claimed Superiority of Malaria Parasite Ex Vivo Viability Reduction Over Observed Parasite Clearance Rate?
Nicholas J White, James A Watson
The Lancet. Infectious Diseases
|
October 3, 2025
Reconsidering the clinical assessment of resistance to slowly eliminated antimalarial drugs in high-transmission settings
Nicholas J White, James A Watson
The New England Journal of Medicine
|
May 9, 2019
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
James A Watson, Aimee R Taylor
The New England Journal of Medicine
|
July 20, 2022
Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
James A Watson, Nicholas J White
Trials
|
October 21, 2020
Correction to: Graphing and reporting heterogeneous treatment effects through reference classes
James A Watson, Chris C Holmes
The Lancet. Microbe
|
May 11, 2022
Tafenoquine for the prevention of Plasmodium vivax malaria relapse
James A Watson, Narimane Nekkab, Michael White
Bioinformatics (Oxford, England)
|
August 11, 2020
A semi-supervised learning framework for quantitative structure-activity regression modelling
Oliver Watson, Isidro Cortes-Ciriano, James A Watson
Page
of 11